Arrowhead Pharmaceuticals to host R&D webinar on ARO-MAPT interim Phase 1/2a data

ARWR•2026-09-29

Arrowhead Pharmaceuticals scheduled an R&D webinar on interim Phase 1/2a data for ARO-MAPT for Oct. 14, 2026, at 11:30 a.m. PDT. A webcast and replay will be posted on its Events and Presentations page.

1. Webinar scheduled

Arrowhead Pharmaceuticals scheduled an R&D webinar for Oct. 14, 2026, at 11:30 a.m. PDT to discuss interim Phase 1/2a data for ARO-MAPT. Webcast access and a replay will be posted on the company’s Events and Presentations page.

Arrowhead Pharmaceuticals to host R&D webinar on ARO-MAPT interim Phase 1/2a data

1. Webinar scheduled

Related News

BlackRock files for ETF share classes on five active mutual funds with nearly $55 billion in assets

Nayax partners with Getnet to expand integrated payments across Latin America, Iberia

Beasley Broadcast prices warrants in private placement for 357,000 shares

NewAmsterdam Pharma doses first patient in Phase 2b SPINOZA trial of obicetrapib in preclinical Alzheimer’s disease

SLB OneSubsea wins ExxonMobil Mozambique subsea systems contract for Rovuma LNG phase 1